Adenylyl cyclase-associated protein 1-targeted nanoparticles as a novel strategy for the treatment of metastatic non-small cell lung cancer
Adenylyl cyclase-associated protein 1-targeted nanoparticles as a novel strategy for the treatment of metastatic non-small cell lung cancer
复制标题
腺苷酸环化酶相关蛋白1靶向纳米颗粒作为治疗转移性非小细胞肺癌的新策略
DOI:
10.3892/ijo.2019.4822
复制
发表时间:
2019-06
影响因子:
5.2
通讯作者:
Wang Changhui
中科院分区:
文献类型:
--
作者:
Liu Yang;Xie Shuanshuan;Zeng Jie;Song Xiaolian;Tan Min;He Dannong;Wang Jie;Wang Ping;Zhu Jun;Wang Changhui
Non-small cell lung cancer (NSCLC) is one of the most fatal cancers worldwide. Adenylyl cyclase-associated protein 1 (CAP1) belongs to a family of cyclase-associated proteins that are involved in the development of cancerous tumors. A previous study by our group confirmed the association between CAP1, lung cancer and the metastasis of cancer cells. In the present study, poly(lactic-polyglycolic acid; PLGA)/CAP1-small interfering (si)RNA nanoparticles were prepared and delivered into A549 cells. The performance of PLGA/siCAP1-siRNA nanoparticles for siRNA delivery was measured based on the results of migration assay and animal experiments. The multifunctional nanoparticles were determined to be capable of inhibiting CAP1 expression, which reduced NSCLC metastasis in vitro and in vivo. Therefore, the findings of the current study highlighted the potential use of PLGA/siCAP1-siRNA nanoparticles for the treatment of NSCLC metastasis.
登录
查看更多内容
影响因子:
5
作者:
Yamazaki, Ken;Takamura, Masaaki;Sakamoto, Michiie
通讯作者:
Sakamoto, Michiie
影响因子:
5.4
作者:
Hua M;Yan S;Deng Y;Xi Q;Liu R;Yang S;Liu J;Tang C;Wang Y;Zhong J
通讯作者:
Zhong J
影响因子:
28.2
作者:
Tabernero, Josep;Shapiro, Geoffrey I.;Burris, Howard A., III
通讯作者:
Burris, Howard A., III
影响因子:
3.5
作者:
Aisner, Dara L.;Marshall, Carrie B.
通讯作者:
Marshall, Carrie B.
影响因子:
168.9
作者:
Lozano, Rafael;Naghavi, Mohsen;Murray, Christopher J. L.
通讯作者:
Murray, Christopher J. L.